Nearly 700,000 women are to be recruited to take part in an NHS artificial intelligence (AI) breast cancer screening trial in England.Five different AI platforms will be tested across 30 sites from April to see if the technology can speed up diagnosis as well as free up radiologists.

The Health and Welfare Committee voted unanimously to introduce the bill, which seeks to cover additional early breast cancer screening for certain at-risk groups.

New research results now published from Lund University's MASAI trial are even better than the initial findings from last year: AI-supported breast screening detected 29% more cases of cancer compared with traditional screening.

During a Case-Based Roundtable event, Laura Huppert, MD, discussed data and considerations around using T-DXd in breast cancer and the need for HER2-negative data with T-DXd.

Julia Bradbury believes new AI breast cancer screening could have detected disease earlierGood Morning Britain

The NHS is launching the world's largest artificial intelligence trial for breast cancer detection - which is set to analyse hundreds of thousands of mammograms across England. The groundbreaking study will examine at least 700,

The NHS is launching the world's biggest trial of AI to detect breast cancer, screening two-thirds of 700,000 women. Five different types of AI will read about 462,000 mammograms at 30 breast cancer screenings later.